37 research outputs found
Comparison of the p24 ELISA (Vironostika) and Combo test (antigen component) against serially diluted p24 antigen-positive controls.
*<p>Average OD (Optical Density) of two runs. An OD ā„0.10 is considered a positive result.</p
Map showing the distribution of 110 research sites as of July 2014.
<p>Map showing the distribution of 110 research sites as of July 2014.</p
Performance of the Determine Ag/Ab Combo test.
<p>Group 1: Antigen positive, antibody negative acute HIV infection (Ag+Abā).</p><p>Group 2: Antigen positive, antibody positive early HIV infection (Ag+Ab+).</p><p>Group 3: Antigen negative, antibody positive chronic HIV infection (AgāAb+).</p><p>Group 4: Antigen negative, antibody negative volunteers without HIV infection (AgāAbā).</p><p>Group 5: Antigen false positive, antibody negative volunteers without HIV infection (AgāAbā).</p><p>Ag: p24 antigen, Ab: HIV antibody, weak pos: the respective assay indicator was fainter than the control indicator. This is considered āpositiveā in our analyses, as per the package insert.</p
HIV incidence and sex at each study site.
<p>*Cases per 100 person-years (95% CI). Stratified by sex only when the difference was statistically significant (p<0.05)</p><p>For more details, see [<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0134438#pone.0134438.ref015" target="_blank">15</a>]</p><p>HIV incidence and sex at each study site.</p
ELISA p24 Antigen Concentration and Viral Load Summary Statistics.
*<p>Upper limit of detection for the VL assay ā=ā15,000,000, any observation that exceeded 15,000,000 recorded as 15,000,001.</p><p>Group 1: Antigen positive, antibody negative i.e. acute HIV infection (Ag+ Abā).</p><p>Group 2: Antigen positive, antibody positive i.e. early HIV infection (Ag+ Ab+).</p
Demographic characteristics of the suspected transmitting partners of incident cases reported to be in HIV discordant couple relationships.
<p>* Data or sample not available from one or both volunteers</p><p>** Transmitting partner reports use of antiretroviral therapy, EDI: Estimated date of infection in the incident case</p><p>Ā°An additional 6 volunteers reported being on ART at or around the time of the transmission event, however their viral load was too low to sequence for linkage analysis</p><p><sup>āŖ</sup> Comparing linked vs. unlinked across volunteer characteristic</p><p><sup>āŖāŖ</sup> Divorced, separated or widowed</p><p>Demographic characteristics of the suspected transmitting partners of incident cases reported to be in HIV discordant couple relationships.</p
First available CD4 count in 272 linked transmitting partners following HIV transmission. Vertical dashed line shows the analysis cut point of 90 days post EDI.
<p>First available CD4 count in 272 linked transmitting partners following HIV transmission. Vertical dashed line shows the analysis cut point of 90 days post EDI.</p
Screened, enrolled and analyzed volunteers by site and gender.
<p>Screened, enrolled and analyzed volunteers by site and gender.</p
Summary of reasons for screen-outs and exclusion from analysis by site.
<p>Percentages shown as a proportion of either total screened (above), or total enrolled (below)</p><p>* Volunteers may be excluded for multiple reasons therefore columns may sum to >100%</p><p>** Systolic blood pressure >140 mm Hg and/or diastolic blood pressure >90 mm Hg</p><p>*** Including headaches, cough, fever, suspected and confirmed malaria</p><p>**** Active STI, including candidiasis, one possible HSV-1 infection, lower abdominal pain in women, and Bartholin's abscess</p>ā”<p>Including suspected and confirmed TB, pneumonia</p>ā <p>Includes 125/184 (67.9%) medical exclusions not linked to infectious disease (e.g., trauma, diabetes, cancer)</p>Ā§<p>Includes 4/17 (23.5%) medical exclusions not linked to infectious disease (3 peripheral neuropathy and 1 inebriation at time of visit)</p
Map of study sites showing source populations, elevation (meters above sea level) and target enrolment.
<p>Map of study sites showing source populations, elevation (meters above sea level) and target enrolment.</p